Length variants of the ABCB1 3'-UTR and loss of miRNA binding sites: possible consequences in regulation and pharmacotherapy resistance

Pharmacogenomics. 2016 Mar;17(4):327-40. doi: 10.2217/pgs.15.175. Epub 2016 Feb 19.

Abstract

Aim: To identify the exact length and possible length variations of the ABCB1 3'-UTR as important regulatory site for miRNA interaction of this drug transporter and its possible contribution to drug resistance.

Materials & methods: 3'-RACE and various standard PCR experiments were performed using cDNA of different human cell lines and liver tissue. The abundance of 3'-UTR fragments was analyzed using quantitative RT-PCR.

Results: Five different ABCB1 3'-UTR length variants were identified. miRNA binding sites were located only on the three longer fragments. Imatinib-resistant leukemia cells expressed predominantly shorter 3'-UTRs, where miRNA binding sites are absent.

Conclusion: Shortening of the ABCB1 3'-UTR causes loss of miRNA-dependent translational control leading to elevated ABCB1 protein levels.

Keywords: MDR1; P-glycoprotein; drug resistance; miRNA; polyadenylation; post-transcriptional regulation.

MeSH terms

  • 3' Untranslated Regions
  • ATP Binding Cassette Transporter, Subfamily B / genetics
  • Antineoplastic Agents / pharmacology*
  • Binding Sites
  • Cell Line, Tumor
  • Computer Simulation
  • Drug Resistance, Neoplasm*
  • Genetic Variation
  • Humans
  • Imatinib Mesylate / pharmacology*
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Polymerase Chain Reaction

Substances

  • 3' Untranslated Regions
  • ABCB1 protein, human
  • ATP Binding Cassette Transporter, Subfamily B
  • Antineoplastic Agents
  • MicroRNAs
  • Imatinib Mesylate